Information Provided By: 
Fly News Breaks for March 16, 2015
AMGN, REGN, SNY
Mar 16, 2015 | 08:23 EDT
Leerink said data on PCSK9 antibodies from Amgen (AMGN) and the Sanofi (SNY)-Regeneron (REGN) partnership presented at this weekend's American College of Cardiology conference was impressive, as both antibodies demonstrated a 50% reduction in cardiovascular event risk at 12-18 months. The firm believes there is a reasonable chance that both studies will be stopped early for success at the interim analyses.
News For SNY;REGN;AMGN From the Last 2 Days
REGN
Apr 24, 2024 | 07:20 EDT
SNY
Apr 22, 2024 | 12:15 EDT
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here
SNY
Apr 22, 2024 | 11:36 EDT
